Media coverage
11
Media coverage
Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Business Wire Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422036848&p=1gw&v=1&x=KtPLm30TsglAdBlLYX6pMA Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Morningstar.com Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422109488&p=1gw&v=1&x=Xe8fwveJLI7FqkA2QzfxKQ Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Yahoo! Finance Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422075228&p=1gw&v=1&x=0IzMV0j5mYbJiuS-xQG-gQ Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet ADVFN US Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422031865&p=1gw&v=1&x=OyIT8fxWmpjsUalzXpWlew Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet APNews.com Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422215609&p=1gw&v=1&x=erFTAhpzbOOz8bQcznaSyw Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Le Lezard.com Country/Territory Canada Date 30/07/24 URL ct.moreover.com/?a=54422065656&p=1gw&v=1&x=Ke2IUKK7kIresSA61QEDIQ Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Tyler Morning Telegraph Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422104780&p=1gw&v=1&x=Sfi-Vu1TKjzky7SMfabuwg Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Bluefield Daily Telegraph Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422344064&p=1gw&v=1&x=iXnePdcngvB49Lc1au-Kow Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet 96.7 3WZ-FM Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422591154&p=1gw&v=1&x=t8VGSIoIkJ02BdwNv_Y0og Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet Platte Valley - News Channel Nebraska Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422605151&p=1gw&v=1&x=ymNe3CKgk01FfcP5cE0UsQ Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun Title CastleVax Inc. Receives $34 Million from BARDA to Continue Advancing Intranasal NDV-based COVID-19 Vaccine into Phase 2b Clinical Efficacy Testing Media name/outlet 1045 TheDan.com Country/Territory United States Date 30/07/24 URL ct.moreover.com/?a=54422855027&p=1gw&v=1&x=E8SpqCFc_w5jYllIdIe1VA Persons Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Weina Sun